Establishment of a genetically diverse hypertensive mouse model and analysis of gene transcription regulation
By crossing genetically diverse mice with salt-sensitive hypertensive mice, a hypertensive mouse model with salt-sensitive and genetic diversity was solved, and the problem of a single genetic background in the traditional model was solved, providing a more close to the population Research resources have improved the effectiveness of complex disease research and the conversion potential of drug development.
Patent Information
- Application Number
- CN202410448683.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-15
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-04-15
AI Technical Summary
Due to the single genetic background of the existing hypertensive mouse model, it is unable to accurately simulate the genetic diversity and disease phenotype of the population, resulting in limited universality of the research results and is unable to effectively replicate individual differences in clinical manifestations, which in turn affects the conversion efficiency of drug development. .
By crossing genetically diverse mice such as A/J or LOT with salt-sensitive hypertensive mice, F1 and F2 generation mice were constructed, and a hypertensive mouse model with salt-sensitive and genetic diversity was obtained, using genotype Cckbr+/- mice were mated and Cckbr-/- mice formed as a genetically diverse hypertensive mouse model.
The constructed hypertensive mouse model has higher genetic diversity and salt sensitivity, which can be closer to the real world population, providing a new resource for studying complex diseases, enhancing the research ability of disease biological mechanisms and drug development conversion potential.
Smart Images

Figure CN118177150B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of new animal varieties, and specifically relates to the establishment of a genetically diverse hypertensive mouse model and gene transcription regulation analysis. Background Art
[0002] Hypertension affects about 1 billion people worldwide, accounting for about 4.5% of the global disease burden. Primary hypertension is a complex disease caused by the combined effects of environmental, genetic and behavioral factors, accounting for more than 90% of hypertensive patients. High salt intake is one of the important environmental factors. There are significant individual differences in the response of blood pressure to salt intake. Based on this, some researchers have successively proposed the concept of "blood pressure salt sensitivity". Salt sensitivity is also an independent risk factor for cardiovascular disease. About 26% of the general population has salt-sensitive blood pressure, while about 60% of the primary hypertension group has salt-sensitive blood pressure. Therefore, effective management of salt-sensitive hypertension is a necessary condition for improving public health services.
[0003] Most of the existing hypertensive mouse models are traditional inbred strains, which are derived from a common ancestor and have a single genetic background. Many pathogenic genes have been eliminated in artificial breeding screening. Genetic homogeneity will make people ignore the potential sites that truly affect human essential hypertension, and will also exaggerate the currently known regulatory factors that affect blood pressure. Studies have shown that flavonoids may play different roles in different rodent strains, which highlights the limitations of traditional animal models. Therefore, the International Complex Trait Consortium (CTC) proposed to create genetically diverse mouse resources.
[0004] Currently, genetically diverse mice are used to conduct extensive research on complex human diseases. For example, Aline deConti et al. (Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse mouse (J The FASEB Journal [J]. 2020, 34.) used 25 genetically diverse mouse strains to study the differences in nonalcoholic fatty liver disease (NAFLD) between individuals and between different sexes. The results showed that the severity of the disease varied by mouse sex and strain, and was related to the expression of key genes. At the same time, due to the huge differences in disease phenotypes among different strains, spontaneous disease animal models have been established using genetically diverse mice. For example, P Wang et al. (WANG P, WANG Y, LANGLEY SA, et al. Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis[J]. 2019.) monitored the occurrence and development of tumors in 293 genetically diverse mice from 18 strains and discovered for the first time that the CC036 strain is a new mouse model for studying spontaneous human gastric cancer.
[0005] Traditional inbred mice such as C57 BL / 6 are widely used in biomedical research due to their phenotypic uniformity and experimental repeatability. However, with the further in-depth study of human diseases, researchers' requirements for animal models are also increasing. Traditional inbred mouse models have a single genetic background, insufficient genetic diversity, and are unable to accurately simulate the genetic background and disease phenotypes of the population, and are unable to accurately locate the disease-causing genes. These shortcomings are becoming increasingly prominent, especially for complex diseases such as hypertension. The maintenance of inbred strains further reduces the accumulation of spontaneous mutations. The universality of experimental results collected from a single strain is limited. The standardization of the genome will make us ignore the phenotypic differences of the disease, hindering many important research discoveries. In addition, the differences between different individuals of mice from inbred strains are attributed to the results of responding to environmental changes.
[0006] In recent years, people have increasingly questioned the usefulness of traditional inbred mouse models, in part because studies using these models have failed to translate into successful treatments. However, a common feature of many traditional mouse models is the lack of genetic diversity. Regardless of the specific mouse strain used, the use of a single genetic background eliminates the impact of individual genetic diversity on the occurrence and development of the disease. Studies have shown that the difference in consistency between preclinical animal experimental results and clinical experimental results is a difficult problem that needs to be solved urgently for human disease research and drug development, especially in the study of complex diseases affected by multiple genes. Putting drugs that are likely to be ineffective and useless into clinical trials is a huge waste of resources and a lack of responsibility for clinical trial patients. Salt-sensitive hypertension has individual differences in clinical manifestations, so it is no longer possible to establish an effective animal model to replicate such diseases using mice with a single genetic background. Summary of the invention
[0007] The technical problem to be solved by the present invention is how to obtain a genetically diverse hypertensive mouse model. The technical problem to be solved is not limited to the described technical subject matter, and those skilled in the art can clearly understand other technical subjects not mentioned herein through the following description.
[0008] In order to solve the above technical problems, the present invention provides the following technical solutions:
[0009] The present invention provides a method for constructing a genetically diverse hypertensive mouse model, the method comprising the following steps: - / - The salt-sensitive hypertensive mice were hybridized to obtain F1 mice, and the F1 mice with the genotype Cckbr + / - The genotype of mice and their littermates is Cckbr + / - The mice were mated and the F2 generation mice had the genotype Cckbr - / - The mice are the genetically diverse hypertensive mouse model.
[0010] The genotype of the A / J mice is Cckbr + / + .
[0011] In the above construction method, the expression level of the Ppp1r1a gene in the genetic diversity hypertensive mouse model is lower than that in the salt-sensitive hypertensive mouse or the A / J mouse.
[0012] In the above construction method, the method comprises the following steps: LOT and genotype Cckbr - / -The salt-sensitive hypertensive mice were hybridized to obtain F1 mice, and the F1 mice with the genotype Cckbr + / - The genotype of mice and their littermates is Cckbr + / - The mice were mated and the F2 generation mice had the genotype Cckbr - / - The mice are the genetically diverse hypertensive mouse model.
[0013] The genotype of the LOT mice was Cckbr + / + .
[0014] In the above construction method, the expression level of the Ppp1r1a gene in the genetic diversity hypertensive mouse model is lower than that in the salt-sensitive hypertensive mouse or the LOT mouse.
[0015] In the above construction method, the genetically diverse hypertensive mouse model is salt-sensitive.
[0016] The genotype is Cckbr + / - The mouse is a mouse in which one homologous chromosome carries the cholecystokinin B receptor (CCKBR) gene, while the other homologous chromosome does not carry the cholecystokinin B receptor (CCKBR) gene.
[0017] The genotype is Cckbr - / - The mouse is a mouse in which neither of the homologous chromosomes carries the cholecystokinin B receptor (CCKBR) gene.
[0018] The LOT mice or A / J mice are both genetically diverse mice.
[0019] In one embodiment of the present invention, the genotype is Cckbr + / - The mouse has the following characteristics: using its genomic DNA as a template, using the three primers Common, WT and Mutant to perform PCR, the resulting PCR product contains a 343 bp DNA fragment and an 800 bp DNA fragment. The genotype is Cckbr + / + The mouse has the following characteristics: using its genomic DNA as a template, using the three primers Common, WT and Mutant for PCR, the PCR product obtained contains a 343bp DNA fragment and does not contain an 800bp DNA fragment. - / - The mouse has the following characteristics: using its genomic DNA as a template, PCR is performed using the three primers Common, WT and Mutant, and the resulting PCR product contains a DNA fragment of 800 bp but does not contain a DNA fragment of 343 bp.
[0020] Common is a single-stranded DNA with the following nucleotide sequence: 5′-CTTAGC CTG GAC AGAGAA GC-3′;
[0021] WT is a single-stranded DNA with the following nucleotide sequence: 5′-CCA AGC TGC TGG CTAAGA AG-3′;
[0022] Mutant is a single-stranded DNA with the following nucleotide sequence: 5'-CTT GGG TGGAGA GGC TAT TC-3'.
[0023] The present invention also provides a genetically diverse hypertensive mouse model, wherein the genetically diverse hypertensive mouse model is obtained by a method comprising the following steps: LOT mice are cross-linked with Cckbr - / - The salt-sensitive hypertensive mice were hybridized to obtain F1 mice, and the F1 mice with the genotype Cckbr + / - The genotype of mice and their littermates is Cckbr + / - The mice were mated and the F2 generation mice had the genotype Cckbr - / - The mice are the genetically diverse hypertensive mouse model;
[0024] Or A / J mice were crossed with Cckbr - / - The salt-sensitive hypertensive mice were hybridized to obtain F1 mice, and the F1 mice with the genotype Cckbr + / - The genotype of mice and their littermates is Cckbr + / - The mice were mated and the F2 generation mice had the genotype Cckbr - / - The mice are the genetically diverse hypertensive mouse model.
[0025] In the above-mentioned genetic diversity hypertensive mouse model, the expression level of the Ppp1r1a gene in the genetic diversity hypertensive mouse model is lower than that in the salt-sensitive hypertensive mouse or the A / J mouse or the LOT mouse.
[0026] In the above-mentioned genetic diversity hypertensive mouse model, the genetic diversity hypertensive mouse model is salt-sensitive.
[0027] The Ppp1r1a gene is the protein phosphatase 1 regulatory inhibitor subunit 1A gene.
[0028] The genetically diverse hypertensive mouse model constructed in the present invention is salt-sensitive and genetically diverse, and is a new resource for studying complex diseases that is closer to real-world people. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 The hybridization strategy and genotype identification results of experimental mice. A, hybridization strategy of experimental mice; B, genotype identification results of mice (B: blank control; N: negative control; P: positive control; M: DNA marker; 74-94: mouse number); C, Western Blot detection of Cckbr -- / , Cckbr + / - and Cckbr + / + Expression of CCKBR protein in mouse kidney (*P<0.05, compared with Cckbr - / - Group comparison, Tukey test, n = 3 / group).
[0030] Figure 2 Blood pressure (systolic and diastolic) measurements of 13 strains of mice (*P<0.05, **P<0.01, compared with Cckbr - / - Group comparison, Tukey test, n = 10 / group).
[0031] Figure 3 Comparison results of blood pressure (systolic and diastolic) of offspring mice from 13 strains. + / + Systolic blood pressure of each group; B, Cckbr of each strain + / + Diastolic blood pressure of each group; C, Cckbr of each strain - / - Systolic blood pressure of each group; D, Cckbr of each strain - / - Group diastolic blood pressure; n = 10 / group.
[0032] Figure 4 HE staining and KLOTHO protein immunohistochemistry of kidneys of mice in A / J, LOT, and FIM strains. A, HE staining of kidneys of mice in A / J, LOT, and FIM strains (scale bar is 100 μm); B, KLOTHO protein immunohistochemistry of kidneys of mice in A / J, LOT, and FIM strains (scale bar is 100 μm).
[0033] Figure 5 LOT strain Cckbr - / - Group and Cckbr + / +Transcriptome sequencing analysis of kidneys of mice in the same group. A, Volcano plot of differentially expressed genes. Red dots: significantly up-regulated genes; blue dots: significantly down-regulated genes; gray dots: no significantly differentially expressed genes (differential gene screening criteria: |log2FC|≥1 and p-Value≤0.05); B, GO enrichment analysis bar chart; C, Pathway enrichment analysis bar chart; D, differentially expressed gene heat map.
[0034] Figure 6 Real time qPCR detection of 20 genes in each strain Cckbr - / - The expression level in the kidney of the mice in the group (R2 is the determination coefficient, which indicates the degree of explanation of the independent variable X on the dependent variable Y. P < 0.05 is considered to be significantly correlated with systolic blood pressure). DETAILED DESCRIPTION
[0035] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.
[0036] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.
[0037] Example 1: Establishment of a mouse model of essential hypertension
[0038] 1. Experimental Methods
[0039] 1. Animals used in the experiment
[0040] LOT mice, whose genotype is Cckbr + / + , recorded in "Chen Xin, Zhao Binbin, Wu Jing, Peng Wanjun, Niu Dong, Han Yunlin, Wang Xinpei, Zhang Lingyan, Liu Jiangning. Screening of EV71 pathogenicity-related genes through genetically diverse mice. Chinese Journal of Comparative Medicine [J]. June 2019, Volume 29, Issue 6", the public can obtain the biological material from the applicant, the Institute of Medical Experimental Animals, Chinese Academy of Medical Sciences. The biological material is only used to repeat the experiments of the present invention and cannot be used for other purposes.
[0041] A / J mice, whose genotype is Cckbr + / +, recorded in "Chen Xin, Zhao Binbin, Wu Jing, Peng Wanjun, Niu Dong, Han Yunlin, Wang Xinpei, Zhang Lingyan, Liu Jiangning. Screening of EV71 pathogenicity-related genes through genetically diverse mice. Chinese Journal of Comparative Medicine [J]. June 2019, Volume 29, Issue 6", the public can obtain the biological material from the applicant, the Institute of Medical Experimental Animals, Chinese Academy of Medical Sciences. The biological material is only used to repeat the experiments of the present invention and cannot be used for other purposes.
[0042] Cckbr - / - Mice, whose genotype is Cckbr - / - , recorded in "Comparative study on transcriptional gene expression and function of human and mouse brain tissue and study on the interaction between dopamine D5 receptor and gastrin receptor in promoting urinary excretion [D]. Graduate School of Peking Union Medical College. 2016". The public can obtain the biological material from the applicant, Institute of Medical Experimental Animals, Chinese Academy of Medical Sciences. The biological material is only used to repeat the experiments of the present invention and cannot be used for other purposes.
[0043] FIM mice, whose genotype is Cckbr + / + The public can obtain the biological material from the applicant, the Institute of Medical Experimental Animals, Chinese Academy of Medical Sciences. The biological material is only used to repeat the experiments of the present invention and cannot be used for other purposes.
[0044] GIG mice: The strain number is 31-11-001-G-000001, the strain name is GIG-EF mice, and will be referred to as GIG in the following.
[0045] POH mice: The strain number is 31-11-001-P-000011, the strain name is POH-DC mice, and will be referred to as POH in the following.
[0046] FEW mice: The strain number is 31-11-001-F-000002, and the strain name is FEW-FD mice, hereinafter referred to as FEW.
[0047] CIS mice: The strain number is 31-11-001-C-000086, the strain name is CIS-AD mice, and will be referred to as CIS in the following.
[0048] NUK mice: The strain number is 31-11-001-N-000011, the strain name is NUK-AC mice, and will be referred to as NUK in the following.
[0049] 129 mice: The strain number is 31-11-001-S-000055, the strain name is Sv129 mice, and will be referred to as 129 in the following.
[0050] NOD mice: The strain number is 31-11-001-N-000005, the strain name is Nod / LtJ mice, and will be referred to as NOD in the following.
[0051] TOFU mice: The strain number is 31-11-001-T-000002, and the strain name is TOFU-FB mice, hereinafter referred to as TOFU.
[0052] PIPING mice: The strain number is 31-11-001-P-000010, the strain name is PIPING-BD mice, and will be referred to as PIPING in the following.
[0053] LEM mice: The strain number is 31-11-001-L-000006, the strain name is LEM-AF mice, and will be referred to as LEM in the following.
[0054] The genetic diversity of the above 13 strains of mice (A / J, FIM, GIG, POH, FEW, CIS, LOT, NUK, 129, NOD, TOFU, PIPING, LEM) and Cckbr - / - All mice were provided by the Institute of Laboratory Animals, Chinese Academy of Medical Sciences. The experimental protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of the Institute of Laboratory Animals, Chinese Academy of Medical Sciences (approval number: PJR23001). All mice were housed in the SPF barrier environment of the Institute of Laboratory Animals, Chinese Academy of Medical Sciences, with free access to food and water.
[0055] The above strain numbers refer to the numbers of mice at the Institute of Laboratory Animals, Chinese Academy of Medical Sciences (https: / / www.cnilas.org / Strains / domain.html).
[0056] 2. Breeding strategy and grouping of mice
[0057] Reproduction strategies such as Figure 1 As shown in A. Female mice (A / J, FIM, GIG, POH, FEW, CIS, LOT, NUK, 129, NOD, TOFU, PIPING, LEM) of 13 strains of genetically diverse mice were selected. Figure 1 GD) and genotype Cckbr - / - The male mice were crossed with the male mice (first round of cross), and the resulting genotype was Cckbr + / - F1 mice ( Figure 1 Cckbr + / - (GD)) and its littermates have the genotype of Cckbr + / -Mouse ( Figure 1 Cckbr + / - (GD)) were mated (second round of hybridization), and then the F2 generation mice were divided into Cckbr according to their genotypes. + / + Group (genotype Cckbr + / + mice), Cckbr + / - Group (genotype Cckbr + / - mice), Cckbr - / - Group (genotype Cckbr - / - mice) and raised them to 3-4 months of age. + / - Group and Cckbr - / - The experimental group, Cckbr + / + Group was the control group.
[0058] Cckbr - / - The group consists of 13 groups, including:
[0059] LOT-Cckbr - / - The group (the parent in the first round of hybridization was LOT) consisted of 5 female mice and 5 male mice.
[0060] FIM-Cckbr - / - The group (the parent in the first round of hybridization was FIM) consisted of 5 female mice and 5 male mice.
[0061] A / J-Cckbr - / - The group (the parent in the first round of hybridization was FIM) consisted of 5 female mice and 5 male mice.
[0062] POH-Cckbr - / - The group (the parent in the first round of hybridization was POH) consisted of 5 female mice and 5 male mice.
[0063] LEM-Cckbr - / - The group (the parent in the first round of hybridization was LEM) consisted of 5 female mice and 5 male mice.
[0064] CIS-Cckbr - / - The group (the parent in the first round of hybridization was CIS) consisted of 5 female mice and 5 male mice.
[0065] PIPING-Cckbr - / - The group (the parent of the first round of hybridization was PIPING) consisted of 5 female mice and 5 male mice.
[0066] TOFU-Cckbr - / -The group (the parent in the first round of hybridization was TOFU) consisted of 5 female mice and 5 male mice.
[0067] NOD-Cckbr - / - The group (the parent in the first round of hybridization was NOD) consisted of 5 female mice and 5 male mice.
[0068] FEW-Cckbr - / - The group (the parents of the first round of hybridization were FEW) consisted of 5 female mice and 5 male mice.
[0069] GIG-Cckbr - / - The group (the parent in the first round of hybridization was GIG) consisted of 5 female mice and 5 male mice.
[0070] NUK-Cckbr - / - The group (the parent in the first round of hybridization was NUK) consisted of 5 female mice and 5 male mice.
[0071] 129-Cckbr - / - The group (the parent of the first round of hybridization is 129) consists of 5 female mice and 5 male mice.
[0072] Cckbr + / + The group consists of 13 groups, including:
[0073] LOT-Cckbr + / + The group (the parent in the first round of hybridization was LOT) consisted of 5 female mice and 5 male mice.
[0074] FIM-Cckbr + / + The group (the parent in the first round of hybridization was FIM) consisted of 5 female mice and 5 male mice.
[0075] A / J-Cckbr + / + The group (the parent in the first round of hybridization was FIM) consisted of 5 female mice and 5 male mice.
[0076] POH-Cckbr + / + The group (the parent in the first round of hybridization was POH) consisted of 5 female mice and 5 male mice.
[0077] LEM-Cckbr + / + The group (the parent in the first round of hybridization was LEM) consisted of 5 female mice and 5 male mice.
[0078] CIS-Cckbr + / + The group (the parent in the first round of hybridization was CIS) consisted of 5 female mice and 5 male mice.
[0079] PIPING-Cckbr + / +The group (the parent of the first round of hybridization was PIPING) consisted of 5 female mice and 5 male mice.
[0080] TOFU-Cckbr + / + The group (the parent in the first round of hybridization was TOFU) consisted of 5 female mice and 5 male mice.
[0081] NOD-Cckbr + / + The group (the parent in the first round of hybridization was NOD) consisted of 5 female mice and 5 male mice.
[0082] FEW-Cckbr + / + The group (the parents of the first round of hybridization were FEW) consisted of 5 female mice and 5 male mice.
[0083] GIG-Cckbr + / + The group (the parent in the first round of hybridization was GIG) consisted of 5 female mice and 5 male mice.
[0084] NUK-Cckbr + / + The group (the parent in the first round of hybridization was NUK) consisted of 5 female mice and 5 male mice.
[0085] 129-Cckbr + / + The group (the parent of the first round of hybridization is 129) consists of 5 female mice and 5 male mice.
[0086] Among them, the genotype is Cckbr + / - The mice have one homologous chromosome carrying the cholecystokinin B receptor (CCKBR) gene and the other homologous chromosome not carrying the CCKBR gene. + / + The mice are mice whose homologous chromosomes carry the CCKBR gene. - / - The mice are mice whose homologous chromosomes do not carry the CCKBR gene.
[0087] Among them, the parent Cckbr + / - The strategy for constructing mice is to knock out the CCKBR gene by replacing a part of exon 3, the entire exon 4, and a part of exon 5 of the CCKBR gene with a neomycin resistance gene.
[0088] 3. Genotype identification of offspring mice
[0089] In step 2, 10 mice (half male and half female) were randomly selected from each group of mice for the following test: the tail tissue (0.1-0.3 cm) of 1-week-old mice was cut and placed in a 1.5 mL sterile EP tube, and PCR genotype identification was performed according to the TaKaRa premixed Taq instructions. The primers used were:
[0090] Common: 5'-CTTAGC CTG GAC AGAGAA GC-3',
[0091] WT:5'-CCA AGC TGC TGG CTAAGA AG-3',
[0092] Mutant: 5'-CTT GGG TGGAGA GGC TAT TC-3'.
[0093] Table 1 PCR reaction system (20 μL)
[0094]
[0095]
[0096] The aforementioned PCR products were collected and subjected to agarose gel electrophoresis.
[0097] 4. Blood pressure measurement of mice
[0098] Using BP-2000 non-invasive blood pressure analyzer to measure Cckbr + / - Group, Cckbr - / - Group and Cckbr + / + The blood pressure of mice in the same group was measured for 4 days in total, the first 3 days were pre-experiments, and the blood pressure data on the 4th day was taken. The specific operation is as follows: Open the BP-2000 analysis software. Calibrate the pressure of the instrument before each measurement, and check the rubber sleeve for leaks before each measurement. Set the temperature of the measurement platform to 36-38°C. Place the mouse in the holder, pass the tail through the sleeve so that the sleeve is located at the base of the mouse's tail, and fix the mouse's tail to the platform with tape. Place the mouse on the platform and wait for 4-5 minutes for its temperature to stabilize. Start the measurement through the program, measure each mouse 20 times, the first 5 times are adaptation data, and the last 15 times are actual data. After the measurement is completed, remove the animal from the platform.
[0099] 5. HE staining
[0100] 5.1) Dewaxing: + / - Group, Cckbr - / - Group and Cckbr + / + The paraffin sections of the mouse kidneys in the group were immersed in xylene for 10 min, and this step was repeated once;
[0101] 5.2) Hydration: Place the slices in absolute ethanol for 5 min, absolute ethanol for 5 min, 95% ethanol for 5 min, 5.3) 85% ethanol for 5 min, 70% ethanol for 5 min, and distilled water for 5 min;
[0102] 5.3) Staining: Place the sections in hematoxylin solution for 4 minutes, rinse with running water for 10 minutes, differentiate with hydrochloric acid and ethanol for 3 seconds, 5.5) rinse with running water for 10 minutes, and soak in eosin solution for 1 minute;
[0103] 5.4) Dehydration: Soak the slices in anhydrous ethanol for 5 minutes and repeat this step twice;
[0104] 5.5) Permeabilization: Soak the slices in xylene for 10 min and repeat this step twice;
[0105] 5.6) Sealing: Use neutral resin to seal the slide, wait for it to dry naturally, and then scan and observe.
[0106] 6. Immunohistochemistry
[0107] 6.1) Dewaxing: Same as HE staining step 5.1;
[0108] 6.2) Hydration: Same as HE staining step 5.2;
[0109] 6.3) Antigen repair: Place the slices in citrate repair solution, microwave on high for 5 minutes, leave with the lid open for one minute, microwave on medium for 3 minutes, leave with the lid open for one minute, microwave on low for 5 minutes, cool the slices naturally, and then wash three times with PBS, 5 minutes each time;
[0110] 6.4) Blocking: Try to dry the water around the sliced tissue, then circle the tissue with an immunohistochemistry pen, add goat serum working solution in the circle, and block for 60 minutes;
[0111] 6.5) Incubate with primary antibody: Pour off the blocking solution, add the diluted solution of KLOTHO protein primary antibody (purchased from Abcam, catalog number ab181373) into the circle, and incubate at 4°C overnight;
[0112] 6.6) Rewarming: Rewarm at room temperature for 1 hour, then wash three times with PBS, 5 minutes each time;
[0113] 6.7) Incubate with secondary antibody: add secondary antibody dilution to the circle, incubate at 37°C for 30 min, and then wash three times with PBS, 5 min each time; add horseradish enzyme-labeled streptavidin to the circle, incubate at 37°C for 30 min, and then wash three times with PBS, 5 min each time;
[0114] 6.8) DAB color development: Try to dry the water around the sliced tissue, add DAB color development solution, let it stand for 2 minutes, observe the color development under a microscope, and then put it in PBS to stop the color development;
[0115] 6.9) Re-staining: add hematoxylin for 1 minute, put into PBS to stop color development, differentiate with hydrochloric acid and ethanol for 3 seconds, rinse with running water for 20 minutes, return to blue with ammonia water for 15 seconds, and rinse with running water for 10 minutes;
[0116] 6.10) Dehydration: Same as HE staining step 5.4;
[0117] 6.11) Permeabilization: Same as HE staining step 5.5;
[0118] 6.12) Sealing: Same as HE staining step 5.6;
[0119] 7. Western Blot
[0120] Dissolve about 20 mg of kidney tissue in 200 μL Trizol, homogenize, and extract total protein. Determine protein concentration using the BCA method. Denature the protein sample at 100°C for 5 minutes before SDS-PAGE. Transfer the protein to the NC membrane, block it with 5% skim milk at room temperature for 1 hour, and incubate with CCKBR primary antibody (1:1000, 4°C overnight, the antibody was purchased from Abcam, catalog number ab77077) and secondary antibody (1:5000, room temperature for 1 hour). Incubate the internal reference (β-actin, 1:10000, room temperature for 1 hour). Perform ECL imaging.
[0121] 8. Transcriptome sequencing
[0122] Cckbr of LOT strain - / - Group and Cckbr + / + The transcriptome sequencing was performed in the two groups. The differentially expressed genes (DEGs) were analyzed using the limma package. The screening criteria for differentially expressed genes were: |log2FC|≥1 and p-Value≤0.05. GO and KEGG pathway enrichment analysis was performed on the differentially expressed genes. The reference genome file was Mus_musculus.GRCm39.dna.primary_assembly.fa. The reference gene annotation file was Mus_musculus.GRCm39.104.gtf. The pheatmap package in R was used to draw the heat map of differentially expressed genes.
[0123] 9. Real time qPCR
[0124] Twenty genes related to blood pressure regulation were selected and verified by real-time fluorescence quantitative PCR (Real time qPCR). The primer sequences of Real time qPCR are shown in Table 1. The Real time qPCR reaction procedure is shown in Table 2.
[0125] Table 2 Real time qPCR primer sequences
[0126]
[0127]
[0128]
[0129] Table 3 Real time qPCR reaction procedure
[0130] step temperature time Pre-denaturation 95℃ 3min transsexual 95℃ 30s annealing 58℃ 30s 40 cycles extend 72℃ 30min
[0131] 10. Statistical analysis
[0132] Primers were designed using NCBI, and Western blot results were analyzed using ImageJ. Experimental results were expressed as mean ± standard deviation (x ± s), and GraphPad Prism 8 statistical software was used for drawing and statistical analysis. The data within each strain group were compared using the Student's t test, and the data between strains were analyzed using one-way ANOVA. P < 0.05 was considered significant. "*" indicates P < 0.05, and "**" indicates P < 0.01.
[0133] 2. Experimental Results
[0134] 1. Laboratory mouse breeding strategy and genotype identification
[0135] The identification results of some offspring mice are as follows Figure 1 As shown in B, B is the blank control (water), N is the negative control (Cckbr + / + Mouse genomic DNA), P is a positive control (Cckbr + / - Mouse genome), M is DNA Marker, and there are 6 bands in the lane where M is located, which are 2000bp, 1000bp, 750bp, 500bp, 250bp, and 100bp from top to bottom.
[0136] The results showed that LOT-Cckbr - / - Group (the parent of the first round of hybridization is LOT), A / J-Cckbr - / - Group (the parent of the first round of hybridization is FIM), POH-Cckbr - / - Group (the parent of the first round of hybridization is POH), LEM-Cckbr - / - Group (the parent of the first round of hybridization is LEM), CIS-Cckbr - / - Group (the parent of the first round of hybridization is CIS), PIPING-Cckbr - / -Group (the parent of the first round of hybridization is PIPING), TOFU-Cckbr - / - Group (the parent of the first round of hybridization is TOFU), NOD-Cckbr - / - Group (the parent in the first round of hybridization is NOD), FEW-Cckbr - / - Group (the parent of the first round of hybridization is FEW), GIG-Cckbr - / - Group (the parent of the first round of hybridization is GIG), NUK-Cckbr - / - Group (the parent of the first round of hybridization is NUK), 129-Cckbr - / - The PCR products of each mouse in the group (the parent in the first round of hybridization was 129) contained an 800 bp DNA fragment and did not contain a 343 bp DNA fragment.
[0137] Figure 1 No. 74 in B is a genotype of Cckbr + / - The agarose gel electrophoresis results of the PCR products of mice (the parent of the first round of hybridization is LOT) showed that they contained 343 bp and 800 bp DNA fragments. No. 75 was a mouse with a genotype of Cckbr + / + The agarose gel electrophoresis results of the PCR products of mice (the parent of the first round of hybridization is LOT) showed that it contained a 343bp DNA fragment and did not contain an 800bp DNA fragment. No. 80 was a mouse with a genotype of Cckbr - / - The agarose gel electrophoresis results of the PCR product of mouse (the parent of the first round of hybridization was LOT) showed that it contained an 800 bp DNA fragment but did not contain a 343 bp DNA fragment.
[0138] Western blot experiments verified the results of Cckbr gene knockout. Figure 1 As shown in C, 1-3 are derived from the Cckbr of LOT mice in the first round of hybridization. - / - Small group of mice, 4-6 of which were derived from the first round of crosses with the Cckbr of .LOT mice + / - Small group of mice, 7-9 of which were derived from Cckbr of LOT mice in the first round of crosses + / + Group mice. - / - The expression of CCKBR protein in the + / + group (P<0.05), indicating that the gene knockout was successful, but due to the parent Cckbr + / -The mouse construction strategy is to replace part of exon 3, all of exon 4 and part of exon 5 of the gene with the neomycin resistance gene to destroy the protein function, while the other regions are retained, so the result is still visible as a lighter protein band.
[0139] 2. Blood pressure measurement in different strains of genetically diverse mice
[0140] Blood pressure was measured in 13 strains of mice. Figure 2 As shown, SBP represents systolic blood pressure, DBP represents diastolic blood pressure, and the left figure shows Cckbr of A / J mice in the first round of hybridization. - / - Mouse, Cckbr + / - Group mice, Cckbr + / + Blood pressure analysis results of the mice in the group. The middle picture shows Cckbr, whose parent in the first round of hybridization is LOT. - / - Mouse, Cckbr + / - Group mice, Cckbr + / + Blood pressure analysis results of the mice in the group. The right picture shows the Cckbr in the first round of hybridization with FIM as the parent. - / - Mouse, Cckbr + / - Group mice, Cckbr + / + The results of blood pressure analysis of the mice in the group showed that there were differences in systolic blood pressure among the three strains of mice: Cckbr - / - Compared with Cckbr + / + There were significant differences, among which Cckbr - / - Mouse Cckbr + / + The systolic blood pressure of mice was significantly increased (P<0.05); - / - Mouse Cckbr + / + The systolic blood pressure of mice was significantly increased (P<0.01); the Cckbr - / - Mouse Cckbr + / + The systolic blood pressure of mice was significantly reduced (P<0.05); there was no significant difference in diastolic blood pressure among the mice of different strains (all P>0.05). + / - Compared with Cckbr + / + There was no significant difference in systolic and diastolic blood pressure (P>0.05). The above results showed that the mice of A / J, LOT and FIM strains were salt sensitive.
[0141] By comparing the strains Cckbr - / - and Cckbr + / + The systolic and diastolic blood pressure of mice were found to be Figure 3), and found that the blood pressure of mice of different strains varied greatly, among which Cckbr - / - There were significant differences in systolic and diastolic blood pressure among the mouse strains (all P<0.001). + / + There were significant differences in systolic blood pressure among mouse strains (P<0.01), but no significant differences in diastolic blood pressure (P>0.05), indicating that genetic diversity affects the blood pressure phenotype of mice.
[0142] 3. Detection of renal pathology in mice with different blood pressure strains
[0143] HE staining revealed that the LOT line Cckbr - / - Inflammatory cell infiltration was found in the kidneys of mice in the A / J strain Cckbr- / - group; glomerular structure was damaged in mice in the FIM strain Cckbr + / + The mice in the group had detached epithelial cells and slight vacuoles in the renal tubules ( Figure 4 (A).
[0144] KLOTHO protein is mainly expressed in kidney tissue and is a protective factor for the kidney. The expression level of KLOTHO protein is closely related to renal function and can be used as a biomarker for early diagnosis or risk stratification of patients with acute kidney injury (AKI) or chronic kidney injury (CKD). - / - , Cckbr + / - and Cckbr + / + The expression levels of KLOTHO protein in the kidney tissues of the three groups of mice were analyzed. The results showed that the A / J strain Cckbr - / - Group Cckbr + / + The expression level of KLOTHO protein in the LOT line Cckbr - / - Group Cckbr + / + The expression level of KLOTHO protein in the FIM strain Cckbr - / - Group Cckbr + / + The expression level of KLOTHO protein in the Figure 4 In conclusion, elevated blood pressure caused some degree of damage to the mouse kidneys.
[0145] 4. Transcriptome sequencing analysis
[0146] The LOT strain Cckbr was analyzed using the limma package. - / - Group and Cckbr + / +Differential gene analysis was performed on the renal transcriptome data of the two groups of mice, and a total of 532 differentially expressed genes (DEGs) were identified. Among these DEGs, 238 genes were upregulated (red dots) and 293 genes were downregulated (blue dots, Figure 5 In order to explore the biological functions of these DEGs, GO and Pathway enrichment analysis were performed. The GO analysis results showed that in the biological process part (BP), DEGs were mainly enriched in signaling pathways such as circadian rhythm regulation and protein kinase activation of G protein-coupled receptors; in the cell component (CC) part, DEGs were mainly enriched in the extracellular region; in the molecular function (MF) part, DEGs were mainly enriched in projects such as insulin-like growth factor binding ( Figure 5 Middle B). Pathway analysis results showed that DEGs were enriched in metabolism and rhythmic gene expression ( Figure 5 C). 50 key genes were screened from the above enriched pathways for differential analysis ( Figure 5 (middle D).
[0147] 5. q-PCR gene verification
[0148] From the 50 key genes of the enriched pathways screened above, 20 genes related to blood pressure regulation were selected for qPCR validation in the kidneys of 13 strains of mice. The correlation analysis between the relative expression of genes and the systolic blood pressure of each strain of mice is shown in the figure. Figure 6 As shown, the results showed that the relative expression of Ppp1r1a gene was negatively correlated with systolic blood pressure (P=0.0234).
[0149] In summary, the present invention hybridized 13 strains of genetically diverse mice with traditional inbred salt-sensitive hypertensive mouse models and found that the salt sensitivity of the offspring genetically diverse mice of different strains was also different. The inventors screened three salt-sensitive strains, namely A / J, LOT and FIM.
[0150] Sodium and water regulation disorder is the main cause of salt-sensitive hypertension. The inventors conducted transcriptome sequencing analysis on the renal tissue of the salt-sensitive LOT strain of mice and found that differentially expressed genes were enriched in the G protein-coupled receptor signaling pathway activated by protein kinase C, extracellular regions and exosomes, binding of insulin-like growth factor (IGF), metabolism and circadian rhythm regulation. A large number of studies have found that targeted interference with clock genes in corresponding animal models will affect renal sodium excretion, BP and neuroendocrine rhythms. Screening 20 key genes related to blood pressure from the enriched pathways for Realtime qPCR revealed that the relative expression level of the protein phosphatase 1 regulatory inhibitor subunit 1A gene (Ppp1r1a gene) was negatively correlated with blood pressure (P=0.0234). The Ppp1r1a gene encodes the inhibitory subunit I1. The phosphorylated form of I1 inactivates protein phosphatase (PP1A), making it unable to bind to Na + -Cl- cotransporter (NCC) binds to the NCC, which activates the NCC, leading to sodium and water retention and increased blood pressure. Due to the large amount of phosphorylation of I1, the original amount of I1 is consumed, making Cckbr - / - The blood pressure of the group was higher, and the amount of Ppp1r1a in the strain was reduced, so the qPCR results showed that the expression level of Ppp1r1a was negatively correlated with blood pressure.
[0151] It is noteworthy that, unlike the other two salt-sensitive strains, the FIM strain of mice Cckbr - / - Group Cckbr + / + The systolic blood pressure of the group was significantly reduced (P<0.05). This is because the whole organism is not a simple sum of its parts, but a new whole in which the interactions between various pathways are complex and contribute to the individual response.
[0152] In addition to the discovery of candidate genes and genetic correlations, screening strains with extreme phenotypes in genetically diverse populations can be used to improve traditional animal models. For example, the inventors found that LOT is a Cckbr - / - Group Cckbr + / + A strain with extremely significant differences in blood pressure between the two groups was identified. Subsequently, by screening the hypertensive individuals in this strain and conducting multi-generation breeding, it is hoped that a genetically diverse salt-sensitive hypertensive mouse model of this strain can be constructed.
[0153] Genetically diverse mice, with their richer trait differences and genetic diversity, have become a new resource for studying complex diseases. These mouse populations and data analysis tools make them a versatile platform for discovering disease biological mechanisms. In addition, by sampling multiple strains of mice, people can more easily generalize drug effects, behavioral differences under different conditions, and various experimental paradigms, rather than limiting their research to C57BL / 6 or traditional inbred strains in the laboratory.
[0154] The present invention hybridizes the salt-sensitive hypertensive mouse model in the traditional inbred background with a genetically diverse mouse strain as a new preclinical resource, aiming to introduce rich genetic variation into the traditional inbred salt-sensitive hypertensive mouse model to investigate the effects of genetic diversity on the phenotype, molecular mechanism and other aspects of salt-sensitive hypertension, as well as the response to intervention or treatment measures. In view of the advantages of this experimental design, and the increasing awareness that genetic background affects various complex traits. In the future, if genetic diversity is incorporated into preclinical studies of various complex diseases, this will greatly improve the overall translational potential of human disease mouse models. In addition, the experimental design of the present invention is widely applicable to human disease mouse models constructed in the form of transgenics, and such models will be closer to the real world population. In these cases, identifying genetic factors that affect the occurrence or severity of the disease will be conducive to a deeper understanding of the key pathways of the pathogenesis of the disease.
[0155] In general, genetically diverse mice are a valuable resource that will be more widely used in the study of various complex trait diseases, becoming a "new tool" for humans to discover the biological mechanisms of diseases and further understand diseases.
[0156] The present invention has been described in detail above. For those skilled in the art, without departing from the purpose and scope of the present invention, and without the need to carry out unnecessary experimental conditions, the present invention can be implemented in a wide range under equivalent parameters, concentrations and conditions. Although the present invention provides specific embodiments, it should be understood that the present invention can be further improved. In a word, according to the principles of the present invention, the application is intended to include any changes, uses or improvements to the present invention, including departure from the disclosed scope in the application, and changes made with conventional techniques known in the art.
Claims
1. A method for constructing a genetically diverse hypertensive mouse model, characterized in that: The method comprises the following steps: hybridizing A / J mice with salt-sensitive hypertensive mice of genotype Cckbr- / - to obtain F1 generation mice, mating mice of genotype Cckbr+ / - in the F1 generation mice with mice of the same litter of genotype Cckbr+ / -, and obtaining F2 generation mice of genotype Cckbr- / -, which are genetically diverse hypertensive mouse models.
2. The construction method according to claim 1, characterized in that: The expression level of the Ppp1r1a gene in the genetic diversity hypertensive mouse model is lower than that in the salt-sensitive hypertensive mouse or the A / J mouse.
3. The construction method according to claim 1 or 2, characterized in that: The genetically diverse hypertensive mouse model is salt sensitive.
4. A method for constructing a genetically diverse hypertensive mouse model, characterized in that: The method comprises the following steps: hybridizing LOT mice with salt-sensitive hypertensive mice with a genotype of Cckbr- / - to obtain F1 generation mice, mating mice with a genotype of Cckbr+ / - in the F1 generation mice with mice with a genotype of Cckbr+ / - in their littermates, and obtaining F2 generation mice with a genotype of Cckbr- / -, which are genetically diverse hypertensive mouse models.
5. The construction method according to claim 4, characterized in that: The expression level of the Ppp1r1a gene in the genetic diversity hypertensive mouse model is lower than that in the salt-sensitive hypertensive mouse or the LOT mouse.
6. The construction method according to claim 4 or 5, characterized in that: The genetically diverse hypertensive mouse model is salt sensitive.
